Abstract 1168: ADAR1 synthetic lethality in BRCA1/2 -mutant tumors defines autocrine interferon poisoning as a targetable vulnerability of cancer cells

Roman M. Chabanon; Liudmila Shcherbakova; Magali Lacroix-Triki; Marine Aglave; Marlène Garrido; Jean Zeghondy; Victor Kriaa; Antoine Gougé; Elodie Edmond; Andrew N. Tutt; Fabrice Barlesi; Yohann Loriot; Suzette Delaloge; Marcel Tawk; Cindy Degerny; Yea-Lih Lin; Barbara Pistilli; Philippe Pasero; Christopher J. Lord; Sophie Postel-Vinay

doi:10.1158/1538-7445.AM2025-1168

Retour

Abstract 1168: ADAR1 synthetic lethality in BRCA1/2 -mutant tumors defines autocrine interferon poisoning as a targetable vulnerability of cancer cells

Article de revue

Avec comité de lecture

Abstract 1168: ADAR1 synthetic lethality in BRCA1/2 -mutant tumors defines autocrine interferon poisoning as a targetable vulnerability of cancer cells

Roman M. Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki, Marine Aglave, Marlène Garrido, Jean Zeghondy, Victor Kriaa, Antoine Gougé, Elodie Edmond, Andrew N. Tutt, …

Cancer research (Chicago, Ill.), Vol.85(8_Supplement_1), pp.1168-1168

21/04/2025

DOI: https://doi.org/10.1158/1538-7445.AM2025-1168

Indicateurs

1 Consultations de la notice

Détails

Titre: Abstract 1168: ADAR1 synthetic lethality in BRCA1/2 -mutant tumors defines autocrine interferon poisoning as a targetable vulnerability of cancer cells
Créateurs - sans rôle: Roman M. Chabanon
Liudmila Shcherbakova
Magali Lacroix-Triki
Marine Aglave
Marlène Garrido
Jean Zeghondy
Victor Kriaa
Antoine Gougé
Elodie Edmond
Andrew N. Tutt
Fabrice Barlesi
Yohann Loriot
Suzette Delaloge
Marcel Tawk
Cindy Degerny
Yea-Lih Lin
Barbara Pistilli
Philippe Pasero
Christopher J. Lord
Sophie Postel-Vinay
Détails de publication: Cancer research (Chicago, Ill.), Vol.85(8_Supplement_1), pp.1168-1168
Identifiants: 99149908309311
Unité académique: Génopolys; Institut de Génétique Humaine - IGH
Langue: English
Type de ressource: Journal article